SPRO
Spero Therapeutics, Inc. · Healthcare
Glaxosmithkline Plc bought $6.0M of Spero Therapeutics, Inc.
10% owner
Bought$5,999,994
$14.00Price
428,571Shares
+30%Stake
What SPRO did for a copier
Prices for SPRO after this filing aren't in yet.
Glaxosmithkline Plc's record
3 other buys with 3 months of prices since 2018: on average +15.9% against the S&P 500, and 2 of 3 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Nov 6. Filed Tue, Nov 7, 7:42 PM ET, after the close. Not investment advice.